Home
>
Stocks
>
Lasa Supergenerics Limited

Lasa Supergenerics Limited

LASA

24.60
1.15
(
4.47
%)
1D

Performance

Today's High
25.65
Today's Low
24.50
52W High
52.0
52W Low
52.0
Open Price
52.0
Prev. Close
52.10
Volume
52.0
Value
522 Cr.

Fundamentals

Market Cap
₹39,910Cr
P/E Ratio(TTM)
NA
P/B ratio
2.21
Industry P/E
-2.47
Debt to Equity
0.03
ROE
-10.01%
EPS(TTM)
-1.13
EPS(TTM)
-1.13
Book Value
25.84
Face Value
1

About

Lasa Supergenerics Limited

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, riclabendazole, rafoxanide, ornidazole, ricobendazole, oxfendazole, closantel base, closantel sodium, nitroxynil, halquinol, and oxyclozanide, as well as 2,6-diiodo-4-nitrophenol; and other API products, such as anthelmintics. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use comprising potassium iodide. It also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai, India.

ITC
2
HDFC Bank
2
Tata Consultancy Services
1
Top Gainers
Tata motors
1.28
SAIL
2.00
Gail
2.80
Top Losers
Britannia
-2
Adani
2